IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
LOS ANGELES, CA - May 28, 2025 ( NEWMEDIAWIRE ) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is advancing its twin strategy of expanding a nationwide mental health clinic network while progressing toward FDA approval of its NMDA-based therapies for suicidal depression and bipolar disorder.
The company's wholly owned subsidiary, HOPE Therapeutics, Inc., a medical and technology-driven company, has signed a term sheet for $7.8 million in debt financing with Universal Capital, LLC ( https://ibn.fm/tZzIa ). The funds will support HOPE's clinic acquisition strategy, starting with the…
Read More
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
The latest news and updates relating to NRXP are available in the company's newsroom at https://ibn.fm/NRXP
Forward Looking Statements
Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading 'Risk Factors' discussed under the caption 'Item 1A. Risk Factors' in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption 'Item 1A. Risk Factors' in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
About IBN
IBN is a cutting-edge communications and digital engagement platform providing tailored Platform Solutions for select private and public companies. Over the course of 19+ years, IBN has introduced over 70 investor facing brands to the investment public and amassed a collective audience of millions of social media followers. These distinctive investor brands amplify recognition and reach as well as help fulfill the unique needs of our rapidly growing and diverse base of client-partners. IBN will continue to expand our branded network of influential properties as well as leverage the energy and experience of our team of professionals to best serve our clients.
IBN's Platform Solutions provide access to: (1) our Dynamic Brand Portfolio (DBP) through 70+ investor facing brands; (2) article and editorial syndication to 5,000+ news outlets; (3) full-scale distribution to a growing Social Media Network (SMN) ; (4) a network of wire solutions via InvestorWire to effectively reach target markets and demographics; (5) Press Release Enhancement to ensure accuracy and impact; (6) a full array of corporate communications solutions; and (7) total news coverage solutions.
For more information, please visit www.IBN.fm
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer
Media Contact
IBN
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Jim Cramer Says He's 'Worried About Brighthouse Financial'
Brighthouse Financial, Inc. (NASDAQ:BHF) is one of the stocks Jim Cramer shared insights on. A caller asked if they should buy, sell, or hold the stock, and Cramer stated: 'I'm worried about Brighthouse Financial… I prefer Chubb if I'm going to be in insurance business. I know Chubb has been a weak stock of late, but it's also 12 times earnings. I'm always willing to buy Chubb at 12 times earnings.' bluebay/ Brighthouse (NASDAQ:BHF) provides annuity and life insurance products designed to support wealth accumulation, income protection, and financial security. The company also manages legacy insurance obligations. Greenlight Capital stated the following regarding Brighthouse Financial, Inc. (NASDAQ:BHF) in its Q1 2025 investor letter: 'The biggest long winner was Brighthouse Financial, Inc. (NASDAQ:BHF), which rose 20.7% during the quarter. According to media reports, the company has hired Goldman Sachs and Wells Fargo to sell itself. There appears to be a lot of interest from large asset managers that would like the opportunity to manage BHF's approximately $120 billion general account. While there is a risk the current market turbulence could derail a deal, absent that we expect the company will be successful in selling itself at a healthy premium.' While we acknowledge the potential of BHF as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
38 minutes ago
- Yahoo
Why Sprouts Farmers Market Plummeted, Then Started to Rebound Today
Key Points Sprouts Farmers Market sailed past analysts' expectations with its second-quarter earnings. Revenue grew by 17%, same-store sales grew by 10%, and profit margins continued to rise. Sprouts may be more expensive than it used to be, but it has a lengthy growth runway ahead of it still. 10 stocks we like better than Sprouts Farmers Market › Shares of better-for-you grocery chain Sprouts Farmers Market (NASDAQ: SFM) are down 3% as of 2 p.m. ET on Thursday, according to data provided by S&P Global Market Intelligence. Sprouts reported second-quarter earnings on Wednesday afternoon that saw sales and earnings per share grow by 17% and 44%, respectively. While these results surpassed analysts' expectations, the stock initially dropped 8% overnight, before partially recovering. Strong results, but mixed reactions Sprouts focuses on the better-for-you portion of the grocery industry. Prioritizing organic, gluten-free, non-GMO, vegan, plant-based, and grass-fed grocery items, the company has carved out a profitable niche in a premium industry. Delivering 17% sales growth in Q2 -- including 10% growth in same-store sales -- the market's adverse initial reaction to the results may seem somewhat odd. However, it is worth remembering that Sprouts' stock has risen more than fivefold in just three years. Along the way, its price-to-earnings ratio ballooned from 12 to 34 today. Said another way, the market was expecting borderline perfection out of Sprouts' stock this quarter, and it apparently came up just shy. Ultimately, Sprouts Farmers Market (the business) continues to fire on all cylinders. The company opened 12 new stores in Q2 and now operates 455 stores in 24 states. Despite this growing footprint, roughly 75% of Sprouts' stores can be found in five states, leaving a massive growth runway ahead. With a pipeline of 130 new store locations already approved, the company's double-digit growth should have ample opportunity to persist for years to come. Best yet for investors, as Sprouts' stores mature, the company's gross margins and EBIT (earnings before interest and taxes) margins have improved for three straight years. Trading at 30 times forward earnings, Sprouts may be more expensive than it was, but its growth story is still nascent. Should you buy stock in Sprouts Farmers Market right now? Before you buy stock in Sprouts Farmers Market, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Sprouts Farmers Market wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $638,629!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,098,838!* Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Josh Kohn-Lindquist has positions in Sprouts Farmers Market. The Motley Fool recommends Sprouts Farmers Market. The Motley Fool has a disclosure policy. Why Sprouts Farmers Market Plummeted, Then Started to Rebound Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Aurora Innovation (AUR) To Release its FQ2 2025 Earnings On July 30
Aurora Innovation, Inc. (NASDAQ:AUR) is one of the Best Tech Stocks to Buy Under $20. On July 9, Aurora Innovation, Inc. (NASDAQ:AUR) announced its fiscal second quarter 2025 earnings release date. The company will hold its earnings call on July 30, 2025. The company released important updates during the fiscal first quarter of 2025, noting that it has closed all remaining software and vehicle claims, achieving ARM 100%, meaning that its AI for driverless operations has been validated and approved. Management noted that two driverless trucks run daily between Dallas and Houston, highlighting that they have completed over 4,000 fully driverless miles. The company expects more customers to join in the coming months, with tens of trucks on the road by the end of 2025. A closeup of a self-driving hardware unit inside the dashboard of a passenger vehicle. Management of Aurora Innovation, Inc. (NASDAQ:AUR) noted that although they started recognizing pilot revenue in Q1, they have only started recognizing broader revenue linked to their commercial driverless operations starting Q2 2025. This revenue will be available as the company reports its second-quarter results. The company ended the fiscal first quarter with $1.2 billion in cash and short-term investments, and management expects this gives the company a smooth runway to fund operations through Q4 2026. Aurora Innovation, Inc. (NASDAQ:AUR) is a tech company that develops the Aurora Driver, an advanced self-driving system designed to operate various vehicle types. While we acknowledge the potential of AUR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
